Bank of Montreal Can Sells 4,190 Shares of VanEck Pharmaceutical ETF $PPH

Bank of Montreal Can lowered its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 26.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,398 shares of the company’s stock after selling 4,190 shares during the period. Bank of Montreal Can owned about 0.21% of VanEck Pharmaceutical ETF worth $1,003,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of PPH. CWM LLC lifted its holdings in VanEck Pharmaceutical ETF by 167.9% in the second quarter. CWM LLC now owns 375 shares of the company’s stock valued at $33,000 after acquiring an additional 235 shares during the period. Banque Cantonale Vaudoise purchased a new stake in shares of VanEck Pharmaceutical ETF during the 1st quarter valued at about $57,000. AE Wealth Management LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 118.4% in the 1st quarter. AE Wealth Management LLC now owns 1,046 shares of the company’s stock worth $95,000 after purchasing an additional 567 shares during the period. HHM Wealth Advisors LLC purchased a new position in shares of VanEck Pharmaceutical ETF in the first quarter worth approximately $123,000. Finally, Creative Financial Designs Inc. ADV boosted its holdings in shares of VanEck Pharmaceutical ETF by 18.1% in the second quarter. Creative Financial Designs Inc. ADV now owns 2,129 shares of the company’s stock worth $187,000 after buying an additional 327 shares during the last quarter.

VanEck Pharmaceutical ETF Trading Down 0.6%

Shares of PPH stock opened at $98.86 on Friday. VanEck Pharmaceutical ETF has a 12 month low of $77.67 and a 12 month high of $100.46. The stock has a market cap of $1.22 billion, a P/E ratio of 20.21 and a beta of 0.54. The company has a 50 day simple moving average of $91.85 and a two-hundred day simple moving average of $88.99.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, October 6th. Stockholders of record on Wednesday, October 1st were paid a $0.3931 dividend. This represents a $1.57 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Wednesday, October 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.